Pfm Health Sciences, LP Biogen Inc. Transaction History

Pfm Health Sciences, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $2.96 Million - $3.34 Million	-11,699 Reduced 5.9%	186,635 $48 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $54.6 Million - $63.1 Million	198,334 New	198,334 $56.5 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $4.12 Million - $5.01 Million	16,333 Added 11.72%	155,659 $43.1 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $27.1 Million - $37.4 Million	139,326 New	139,326 $37.2 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $3.78 Million - $4.86 Million	-16,900 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $32.6 Million - $42.6 Million	-115,372 Reduced 87.22%	16,900 $4.78 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $7.83 Million - $12.5 Million	30,238 Added 29.64%	132,272 $45.8 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $3.05 Million - $3.58 Million	-12,570 Reduced 10.97%	102,034 $28.5 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $5.88 Million - $8.85 Million	24,888 Added 27.74%	114,604 $28.1 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $23.8 Million - $27.4 Million	89,716 New	89,716 $25.5 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $21 Million - $27.8 Million	-81,013 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $39.6 Million - $50.2 Million	-147,315 Reduced 64.52%	81,013 $25.6 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $50.2 Million - $69.4 Million	228,328 New	228,328 $67.8 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.